Etoposide
Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
What Etoposide Means in Everyday Medical Language
Etoposide is a chemotherapy medicine used to treat certain types of cancer. It is sometimes called VP-16. This drug works by blocking an enzyme called topoisomerase II, which cancer cells need to divide and repair their DNA. By stopping this enzyme, etoposide can cause damage to cancer cells and help kill them. It is often used together with other chemotherapy drugs to improve treatment effectiveness.
Why Etoposide Can Matter in Cancer Care
Etoposide is approved to treat cancers such as small cell lung cancer and some testicular cancers. It is also being studied for other types of cancer. Because cancer cells grow and divide quickly, they rely heavily on enzymes like topoisomerase II. Etoposide targets this process, making it a useful part of chemotherapy plans. It is often combined with other drugs that attack cancer cells in different ways, such as in the ABVE chemotherapy regimen used for children with Hodgkin lymphoma. Using multiple drugs together can increase the chance of controlling the cancer.
What Patients Might See or Hear About Etoposide
Patients and families may hear the term etoposide during treatment discussions, see it in medical reports, or find it listed in treatment plans. It may also appear under the name VP-16 or as etoposide phosphate, a related form of the drug. Etoposide is usually given by mouth or injection into a vein. Side effects can include low blood cell counts, nausea, vomiting, hair loss, and increased risk of infection. Because it is often part of combination chemotherapy, patients may hear about it alongside other drugs like doxorubicin, bleomycin, and vincristine.
Where Etoposide May Appear in Cancer Care
Etoposide can be mentioned in various places such as medical records, treatment plans, clinical trial information, or drug information pages. It is sometimes part of chemotherapy regimens like ABVE, which combines four drugs to treat Hodgkin lymphoma in children. Clinical trials may also list etoposide as a study drug for new cancer treatments. Understanding where and how etoposide fits into a treatment plan can help patients and caregivers ask informed questions.
Common Sources of Confusion and How to Read Etoposide in Context
Etoposide may appear under different names, including VP-16 or etoposide phosphate (also called Etopophos). This can cause confusion if patients see different terms in reports or discussions. It’s important to ask the care team what the term means in the specific context of the patient’s diagnosis and treatment plan. Seeing the word etoposide alone does not mean a particular treatment is planned or that it is a diagnosis. Instead, it is one part of a larger treatment approach tailored to the individual.
Safety and Next Steps for Patients and Caregivers
This information is meant to help patients and families understand what etoposide is and how it may be used in cancer care. It is not a recommendation or a complete guide to treatment. Side effects and treatment plans vary widely between patients. The best next step if you see or hear about etoposide is to ask your health care team how it applies to your or your loved one’s specific situation. They can explain why it is being used, what to expect, and how side effects will be managed to support the best possible care experience.
Sources
Public source information used for this glossary entry includes: